Noninvasive Detection of EGFR T790M in Gefitinib or Erlotinib Resistant Non-Small Cell Lung Cancer

Ítems similars

• Effects of erlotinib in EGFR mutated non-small cell lung cancers with resistance to gefitinib
  per: Costa, Daniel B., et al.
  Publicat: (2008)
• MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
  per: Bean, James, et al.
  Publicat: (2007)
• Development of Central Nervous System Metastases in Patients with Advanced Non-Small Cell Lung Cancer and Somatic EGFR Mutations Treated with Gefitinib or Erlotinib
  per: Heon, Stephanie, et al.
  Publicat: (2010)
• DISSECT Method Using PNA-LNA Clamp Improves Detection of EGFR T790m Mutation
  per: Guha, Minakshi, et al.
  Publicat: (2013)
• The Impact of Initial Gefitinib or Erlotinib versus Chemotherapy on Central Nervous System Progression in Advanced Non–Small Cell Lung Cancer with EGFR Mutations
  per: Heon, Stephanie, et al.
  Publicat: (2012)